2BB score and signals
Entrada Therapeutics, Inc.’s current 2BB score is 50 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 75 | High |
| Momentum | 77 | Improving |
| Financial strength | 16 | Very Weak |
| Quality | 98 | Very Strong |
| Risk | 50 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2016 |
| Employees | 152 |
| 52-week range | $4.11 – $16.45 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.9486 | — | $11.46M |
| 2026-11-04 | — | -1.0302 | — | $5.36M |
| 2026-08-12 | — | -1.071 | — | $419,658.00 |
| 2026-05-07 | -0.95 | -1.0575 | $875,000.00 | $1.42M |
Related companies
2BBBullish & Bearish